Skip to main content

Postpartum depression drug needs to be available in Canada ‘ASAP’, experts say – National

The approval of a fast-acting, short-term medication in the United States to treat postpartum depression has Canadian maternal health experts and advocates hoping people north of the border will soon have access to the same treatment.

Media Miss by the Right

See who else is reporting on this story and which side of the political spectrum they lean. To read other sources, click on the plus signs below.

Learn more about this data

Left 86%

Center 14%

Right 0%

Bias Distribution

Click to see headlines

10 other sources covering this story

Total News Sources


Leaning Left




Leaning Right


Last Updated

10 months ago

Bias Distribution Powered by Ground News